Company Profile

Bayou Biolabs (AKA: Sybtrel Biotechnology)
Profile last edited on: 11/25/20      CAGE: 8WN29      UEI: NCHQEEP66GP3

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

4724 Hessmer Avenue
Metairie, LA 70002
Location: Single
Congr. District: 01
County: Jefferson Parish

Public Profile

Previously known as Sybtrel Biotechnology, (name change in 1995), Bayou Biolabs offers a complete line of DNA Ladders, pUC and M13 vectors, and ready to ligate vectors. The firm offers Custom Plasmid Preparation from milligram to gram scale, supercoiled purified, for applications such as gene therapy; Custom Protein Preparation of proteins or enzymes, from milligram to multi-gram scale, the protein is purified chromatographically according to the customer’s specifications. A complete line of DNA Ladders, pUC and M13 vectors, molecular biology enzymes, and ready to ligate vectors. Recombinant Enzymes tagged with polyhistidine and purified by metal chelate affinity chromatography. The firm offers a breakthrough in plasmid purification, achieves virtually 100% supercoiled plasmid product and iin plasmid purification, removes nearly all chromosomal DNA contamination from plasmid preparations. The largest collection of natural plasmids in the world, containing genes for antibiotic resistance, heavy metal resistance, inc groups, etc.(click here to learn more

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1994 1 NIH $81,000
Project Title: One pot enzymatic synthesis of oligonucleotides
1993 1 NIH $50,000
Project Title: Construction of an automated plasmid prep instrument
1991 1 NIH $50,000
Project Title: Protein Production Using a New Expression Vector System
1989 1 NIH $50,000
Project Title: Development of a new DNA sequencing instrument

Key People / Management

  Edward D Hyman -- President

Company News

There are no news available.